Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2020/04/024598
CTRI/2020/04/024598
Active, not recruiting
Phase 3

Randomized controlled trial to compare the effect of intermittent versus daily vitamin D supplementation on vitamin D status in children with nephrotic syndrome

Jawaharlal Nehru medical college0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Jawaharlal Nehru medical college
Status
Active, not recruiting
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Children in the age group of \<14 years diagnosed as SDNS/FRNS, who have serum vitamin D levels of \> 20 ng/dL, shall be considered for enrolment in this trial.

Exclusion Criteria

  • •1\. Age more than 14 years or \<1year
  • •2\. Refusal to give consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Diet and exercise in diabetes patients with Sarcopenia
CTRI/2022/04/042186INDIAN COUNCIL OF MEDICAL RESEARCH
Not yet recruiting
Not Applicable
A study of the effect of fentanyl boluses versus infusion on surgical plethysmographic index during surgery
CTRI/2020/11/029056Kasturba Medical College
Active, not recruiting
Not Applicable
Repeated application of bone marrow-derived stem cells to treat chronicpost-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-000595-33-NLGoethe University Frankfurt676
Recruiting
Phase 3
Randomized controlled trial to compare the effects of single versus repeated intracoronary application of autologous bone marrow-derived mononuclear cells on total and SHFM-predicted mortality in patients with chronic post-infarction heart failure;REpetitive Progenitor cEll therapy in Advanced chronic hearT failure (REPEAT trial)Heart failure10019280
NL-OMON47617Goethe University Frankfurt20
Active, not recruiting
Phase 1
Repeated application of bone marrow-derived stem cells to treat chronic post-infarction heart failureChronic post-infarction heart failure due to an at least 3 months old myocardial infarction, treated with optimal medication according to the evidence-based guidelines, in NYHA stadium II-IIIand with open vessel / bypass sullpying the previously infarcted areaTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]
EUCTR2011-000595-33-DEGoethe University Frankfurt676